You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR VASOSTRICT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for VASOSTRICT

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02975999 ↗ Use of Vasopressin Following the Fontan Operation Suspended Advocate Health Care Phase 2/Phase 3 2016-12-01 The purpose of this study is to determine whether Vasopressin following the Fontan operation will decrease chest tube output and duration.
NCT04093050 ↗ Safety and Pharmacokinetics of Vasopressin in Healthy Volunteers Completed Endo Pharmaceuticals Phase 1 2019-10-10 Open-label Phase I pharmacokinetic (PK) study of Vasostrict® (vasopressin injection, USP) in healthy volunteers.
NCT05193370 ↗ Pilot RCT of Angiotensin II vs. Vasopressin in Septic Shock Not yet recruiting La Jolla Pharmaceutical Company Phase 4 2022-01-03 This will be a randomized controlled unblinded pragmatic single-center pilot trial of the use of vasopressin vs. angiotensin II as a second-line vasopressor in patients with septic shock and persistent hypotension despite moderate-to-high doses of norepinephrine.
NCT05193370 ↗ Pilot RCT of Angiotensin II vs. Vasopressin in Septic Shock Not yet recruiting National Center for Advancing Translational Science (NCATS) Phase 4 2022-01-03 This will be a randomized controlled unblinded pragmatic single-center pilot trial of the use of vasopressin vs. angiotensin II as a second-line vasopressor in patients with septic shock and persistent hypotension despite moderate-to-high doses of norepinephrine.
NCT05193370 ↗ Pilot RCT of Angiotensin II vs. Vasopressin in Septic Shock Not yet recruiting University of New Mexico Phase 4 2022-01-03 This will be a randomized controlled unblinded pragmatic single-center pilot trial of the use of vasopressin vs. angiotensin II as a second-line vasopressor in patients with septic shock and persistent hypotension despite moderate-to-high doses of norepinephrine.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for VASOSTRICT

Condition Name

Condition Name for VASOSTRICT
Intervention Trials
Healthy Volunteer Safety Study 1
Pleural Effusion 1
Septic Shock 1
Single-ventricle 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for VASOSTRICT
Intervention Trials
Shock, Septic 1
Shock 1
Univentricular Heart 1
Pleural Effusion 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for VASOSTRICT

Trials by Country

Trials by Country for VASOSTRICT
Location Trials
United States 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for VASOSTRICT
Location Trials
New Mexico 1
Texas 1
Florida 1
Illinois 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for VASOSTRICT

Clinical Trial Phase

Clinical Trial Phase for VASOSTRICT
Clinical Trial Phase Trials
Phase 4 1
Phase 2/Phase 3 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for VASOSTRICT
Clinical Trial Phase Trials
Completed 1
Not yet recruiting 1
Suspended 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VASOSTRICT

Sponsor Name

Sponsor Name for VASOSTRICT
Sponsor Trials
National Center for Advancing Translational Science (NCATS) 1
University of New Mexico 1
Advocate Health Care 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for VASOSTRICT
Sponsor Trials
Other 2
Industry 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.